Basic information Safety Supplier Related

SIS3

Basic information Safety Supplier Related

SIS3 Basic information

Product Name:
SIS3
Synonyms:
  • SIS3
  • (2E)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-propenone hydrochloride
  • 2-Propen-1-one,1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-,hydrochloride (1:1), (2E)-
  • 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline Monohydrochloride
  • Caneritinib(CI-1033)
  • SIS3 hydrochloride
  • SIS3 HCl
  • SIS 3 HCL;SIS-3 HCL
CAS:
521984-48-5
MF:
C28H27N3O3HCl
MW:
0
Mol File:
521984-48-5.mol
More
Less

SIS3 Chemical Properties

Melting point:
>161°C (dec.)
storage temp. 
2-8°C
solubility 
H2O: <2mg/mL
form 
powder
color 
yellow
InChIKey
CDKIEBFIMCSCBB-CALJPSDSSA-N
More
Less

Safety Information

WGK Germany 
3
More
Less

SIS3 Usage And Synthesis

Uses

Sugar insensitive 3 (SIS3) has been used as smad3?inhibitor in various cells.

Definition

ChEBI: SIS3 is a hydrochloride resulting from the reaction of SIS3 free base with 1 mol eq. of hydrogen chloride. It has a role as a Smad3 inhibitor. It contains a SIS3 free base(1+).

Biological Activity

sis3 is an inhibitor of smad3.the receptor-associated smads, such as smad2 and smad3, directly interact with activated tgf-receptor type i. smads form heteromeric complexes with smad4, which is a common mediator for all smad pathways.

Biochem/physiol Actions

Sugar insensitive 3 (SIS3) promotes drug-induced apoptosis and hinders the function of adenosine triphosphate (ATP)-binding cassette (ABC) transporter (ABCB1) and ABCG2. It resensitizes ABCB1 and ABCG2 overexpressed in cancerous cells, which contributes to chemotherapeutics.

in vitro

in the reporter assay, it was found that the increased luciferase activity of p3tp-lux could be abrogated by the sis3 treatment in a dosedependent manner. immunoprecipitation revealed sis3 attenuated the tgf-1-induced phosphorylation of smad3 and interaction of smad3 with smad4. whereas, sis3 did not affect the phosphorylation of smad2. in addition, it was found that sis3 attenuated the effects of tgf-1 by reducing the transcriptional activity. sis3 could also inhibit the myofibroblast differentiation of fibroblasts by tgf-1. moreover, sis3 diminished the constitutive phosphorylation of smad3 completely [1].

in vivo

animal study showed that, in tie2-cre;loxp-egfp mice, ages could induce endomt. immunoprecipitation and western blotting showed that smad3 could be activated by ages but was inhibited by sis3 in both mmecs and in stz-induced diabetic nephropathy. furthermore, confocal microscopy and real-time pcr showed that sis3 could abrogate endomt, reduce renal fibrosis, as well as retard nephropathy progression [2].

IC 50

3 μm

storage

Store at -20°C

References

[1] jinnin m et al. characterization of sis3, a novel specific inhibitor of smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. mol pharmacol. 2006 feb;69(2):597-607.
[2] li j et al. blockade of endothelial-mesenchymal transition by a smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. diabetes.2010 oct;59(10):2612-24.

SIS3Supplier

Tianjin Kailiqi Biotechnology Co., Ltd. Gold
Tel
15076683720
Email
klq@cw-bio.com
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66099280 17798518460
Email
cfzhang@aikonchem.com
TOKYO CHEMICAL INDUSTRY CO., LTD.
Tel
03-36680489
Email
Sales-JP@TCIchemicals.com
TCI Europe
Tel
320-37350700
Email
sales@tcieurope.eu
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com
More
Less